{"DataElement":{"publicId":"5805698","version":"1","preferredName":"Busulfan Area under Curve Laboratory Value","preferredDefinition":"The result or the value of target area under the curve (AUC) value for busulfan administration.","longName":"BU_AUC_LAB_VAL","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5794962","version":"1","preferredName":"Busulfan Area under Curve Laboratory","preferredDefinition":"A synthetic derivative of dimethane-sulfonate with antineoplastic and cytotoxic properties.  Although its mechanism of action is not fully understood, busulfan appears to act through the alkylation of DNA.  Following systemic absorption of busulfan, carbonium ions are formed, resulting in DNA alkylation and DNA breaks and inhibition of DNA replication and RNA transcription. (NCI04)_The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated._A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","longName":"2861424v1.0:5794960v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2861424","version":"1","preferredName":"Busulfan","preferredDefinition":"A synthetic derivative of dimethane-sulfonate with antineoplastic and cytotoxic properties.  Although its mechanism of action is not fully understood, busulfan appears to act through the alkylation of DNA.  Following systemic absorption of busulfan, carbonium ions are formed, resulting in DNA alkylation and DNA breaks and inhibition of DNA replication and RNA transcription. (NCI04)","longName":"C321","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Busulfan","conceptCode":"C321","definition":"A synthetic derivative of dimethane-sulfonate with antineoplastic and cytotoxic properties.  Although its mechanism of action is not fully understood, busulfan appears to act through the alkylation of DNA.  Following systemic absorption of busulfan, carbonium ions are formed, resulting in DNA alkylation and DNA breaks and inhibition of DNA replication and RNA transcription. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67B1BBA8-05A7-5961-E040-BB89AD4306C0","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5794960","version":"1","preferredName":"Area under Curve Laboratory","preferredDefinition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.:A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","longName":"C64774:C37984","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Area Under Curve","conceptCode":"C64774","definition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E395C07-D1AE-29B3-E053-F662850AE535","latestVersionIndicator":"Yes","beginDate":"2017-04-28","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-28","modifiedBy":"ONEDATA","dateModified":"2017-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E395C07-D1BF-29B3-E053-F662850AE535","latestVersionIndicator":"Yes","beginDate":"2017-04-28","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-28","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3631743","version":"1","preferredName":"Area Under Curve Value","preferredDefinition":"the value for the area under the curve (AUC) of an agent.","longName":"AUC_VAL","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3636172","version":"1","preferredName":"Area under Curve Value","preferredDefinition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.:A numerical quantity measured or assigned or computed.","longName":"C64774:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Area Under Curve","conceptCode":"C64774","definition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D00799B8-2CD2-FE41-E040-BB89AD43654B","latestVersionIndicator":"Yes","beginDate":"2012-12-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-04","modifiedBy":"ONEDATA","dateModified":"2012-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFBA8E70-2176-3B42-E040-BB89AD43651B","latestVersionIndicator":"Yes","beginDate":"2012-11-30","endDate":null,"createdBy":"WONGW","dateCreated":"2012-11-30","modifiedBy":"REEVESD","dateModified":"2016-05-19","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Busulfan AUC result:","type":"Preferred Question Text","description":"Busulfan AUC result:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E93C2B5-EE6B-64D4-E053-F662850A8BA5","latestVersionIndicator":"Yes","beginDate":"2017-05-02","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-05-02","modifiedBy":"FEIBUSHL","dateModified":"2022-01-28","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 CDE definition updated EL 1/3/2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}